Atlas Trials

Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer Patients

Clinical trial NCT02812277 · UNKNOWN

Trial details

NCT number
NCT02812277
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2016-07-01
Primary completion
2017-07-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.